ACCENDRA HEALTH INC/VA/ (ACH) Latest Filing Signal

Latest Filing: 10-K  |  Filed Feb 20, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for ACCENDRA HEALTH INC/VA/?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, ACCENDRA HEALTH INC/VA/'s filing signal turned positive.
earningsVibe SuperAnalyst™ Verdict: TURNED POSITIVE

Signal Performance — Stock Price Since Filing

30-Day Change
-21.84%
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Turned Positive
GEMINI
Turned Negative
CLAUDE
Turned Positive
CHATGPT
Turned Positive

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does ACCENDRA HEALTH INC/VA/ actually do?
Answer:
Accendra Health, Inc. is a nationwide provider of products, technology, and services supporting health beyond the hospital, connecting patients, providers, and insurers. The company offers a range of products and services for in-home care, including diabetes treatment, home respiratory therapy, and sleep apnea treatment, alongside other home medical equipment and patient care products like ostomy and wound care supplies. Revenues are generated through fee-for-service and capitation arrangements with government and commercial payors. Accendra Health aims to provide value by enabling home-based care while reducing treatment costs, leveraging technology for efficient business transactions. The company completed the sale of its Products & Healthcare Services (P&HS) business on December 31, 2025, retaining a 5% equity interest.
Question:
What are ACCENDRA HEALTH INC/VA/'s revenue drivers?
Answer:
Revenues are generated through fee-for-service and capitation arrangements with government and commercial payors for equipment, supplies, and services provided to patients. Key product categories contributing to revenue include sleep therapy, ostomy, and urology.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required